Industry & policyHumans2,747 participantsCross-sectional study

Changes in statin therapy eligibility under the 2026 versus 2018 dyslipidemia guidelines

Figure 1 from American Journal of Preventive Cardiology
Open the figure at full size
Figure 1Spitz et al.

American Journal of Preventive Cardiology

The paper

Inova Health System · NewYork–Presbyterian Hospital

American Journal of Preventive Cardiology · 26 Jun 2026

doi.org/10.1016/j.ajpc.2026.101719PubMed 42830764